Related Experiment Video
Updated: Jun 6, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count
Andreas Weiss1, Stephan Grueninger, Dorothée Abramowski
1Neuroscience Discovery, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland. andreas-1.weiss@novartis.com
Abstract:
Huntington's disease is caused by a gain-of-function neurotoxic mutation in normally neuroprotective huntingtin. Sensitive assays are required to discriminate mutant huntingtin from wild-type huntingtin. We have developed a normalized 384-plate assay for determination of mutant and wild-type huntingtin. Based on a single pipetting step, the sensitive assay uses two antibody pairs for simultaneous mutant and wild-type huntingtin time-resolved fluorescence resonance energy transfer detection combined with PicoGreen quantification of double-stranded DNA. The assay can be used for discovery of drugs reducing mutant huntingtin over wild-type huntingtin and for assessing the value of huntingtin as a disease progression marker, and it is adaptable to other proteins of interest.

